Sign in to fuzzto save your conversations, follow your research and come back anytime.
Shalby
SHALBY
NSE
BSE
NSEBSESectorHealthcare Services
152.64
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Shalby Ltd shows recovering hospital utilization and strong MedTech growth, but rising debt and falling cash reserves require monitoring.
Net debt improved from ₹101.38 Cr to -₹544.83 Cr from Q1 FY26 to Q1 FY27 — building a stronger cash buffer
Cash reserves fell from ₹1,088.71 Cr to ₹670.86 Cr over five quarters — tightening available liquidity
Hospital occupancy rose from 45% to 51% from Q1 FY26 to Q1 FY27 — better bed utilization across facilities
Debt to equity ratio climbed from 0.30x to 0.46x from Q1 FY26 to Q1 FY27 — increasing financial leverage
Return on capital employed grew from 6.8% to 9.4% over five quarters — enhanced capital efficiency
International patient revenue share dropped from 56% to 42% over the period — reducing high-margin overseas income
MedTech revenue expanded from ₹3.64 Cr to ₹472 Cr from Q1 FY26 to Q1 FY27 — driving rapid top-line growth
Annualized ROCE declined from 12.5% to 6.7% from Q1 FY26 to Q1 FY27 — signaling lower long-term capital returns
Pre-tax margin recovered from 3.3% to 13.1% between Q3 FY26 and Q1 FY27 — stabilizing core profitability
Gross borrowings rose from ₹987.33 Cr to ₹1,215.69 Cr over five quarters — adding to interest expenses
